Interview
In conversation with
Meri Beckwith
Meri Beckwith is shortening clinical trials with Lindus Health, replacing bloated processes and misaligned incentives with fixed-cost milestones and a software-first operating system. Think participant-centric design and automated execution that remove friction for sites and patients—so completion, data quality, and speed move in the same direction. The proposition is blunt: make the CRO’s economics match sponsor success, then use AI to make fast the default.
The answer was then obvious: choose a different business model that aligned the interests of CROs, patients and sponsors, and use technology to improve efficiency.
Beckwith’s conviction comes from both sides of the table—investor watching delays pile up as invoices grew, and participant experiencing broken portals and needless site visits. Eroom’s law framed the root cause: trials, not science, were the bottleneck. Lindus Health’s response is structural—fixed-cost, milestone contracts, an AI-powered operating system, and designs that minimize dropout—so what’s good for patients and sites is finally good for timelines and sponsors.
Lessons from 80+ Trials:
Align Incentives, Then Automate
What we cover
-
How a fixed-cost, milestone model changes CRO behavior and sponsor outcomes
-
Why Eroom’s law points to trial operations—not biology—as the efficiency gap to close
-
What Lindus’s AI-powered platform automates to cut timelines up to 2×
-
Where participant-centric design reduces dropout and friction at sites
-
Which fundraising and team habits keep velocity high—tight processes, applied AI, and digital fluency
Meri Beckwith is the founder and co-CEO of Lindus Health, a new kind of Contract Research Organization running radically faster, more reliable clinical trials for life science pioneers. He was previously a venture capital investor in MedTech and biotech companies, where he experienced the pain points around inefficient clinical trials firsthand.
About
Meri Beckwith
Connect
